Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cis-regulatory Sequences02:02

Cis-regulatory Sequences

11.9K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.9K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

4.2K
4.2K
Global Regulatory Systems01:28

Global Regulatory Systems

735
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
735
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

5.3K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.3K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

17
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
17
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

575
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
575

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered Lipid Metabolism in CNS Demyelination and Remyelination Are Key Elements Driving Progressive MS.

International journal of molecular sciences·2025
Same author

MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness.

Frontiers in immunology·2025
Same author

The CD74 inhibitor DRhQ improves short-term memory and mitochondrial function in 5xFAD mouse model of Aβ accumulation.

Metabolic brain disease·2025
Same author

CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells.

PLoS biology·2024
Same author

MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy.

Cancers·2024
Same author

MIF contribution to progressive brain diseases.

Journal of neuroinflammation·2024
Same journal

Epidermal Dominance of Metabolically Constrained Immune Niches Underpins Immune Activation Signatures and Clinical Severity in Psoriatic Disease.

Immunology·2026
Same journal

Thymic APC Networks Orchestrate T-Cell Selection: Mechanisms and Therapeutic Opportunities in Immune Disorders.

Immunology·2026
Same journal

Immune Checkpoints in Leukaemia as Gatekeepers of Immuno-Modulation.

Immunology·2026
Same journal

Senescent Human Liver Endothelial Cells Mediate CD4<sup>+</sup> T Cell Recruitment via ICOSL.

Immunology·2026
Same journal

The Transcription Factor EGR2 Plays a Central Role in the Expansion and Function of TCRαβ<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> Double Negative T Cells in lpr Lupus Mice.

Immunology·2026
Same journal

Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.

Immunology·2026
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

2.5K

Regulatory B cells in experimental stroke.

Hilary A Seifert1,2, Arthur A Vandenbark1,2,3, Halina Offner1,2,4

  • 1Neuroimmunology Research, VA Portland Health Care System, Portland, OR, USA.

Immunology
|January 10, 2018
PubMed
Summary
This summary is machine-generated.

Regulatory B cells show promise for treating stroke by reducing brain damage and improving outcomes. This therapy, even when given 24 hours post-stroke, offers a wider treatment window than current options like tissue plasminogen activator (tPA).

Keywords:
B cellsbraincell therapyneuroinflammationregulation/suppression

More Related Videos

Assessing Phagocytic Clearance of Cell Death in Experimental Stroke by Ligatable Fluorescent Probes
07:14

Assessing Phagocytic Clearance of Cell Death in Experimental Stroke by Ligatable Fluorescent Probes

Published on: May 27, 2014

8.5K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K

Related Experiment Videos

Last Updated: Feb 15, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

2.5K
Assessing Phagocytic Clearance of Cell Death in Experimental Stroke by Ligatable Fluorescent Probes
07:14

Assessing Phagocytic Clearance of Cell Death in Experimental Stroke by Ligatable Fluorescent Probes

Published on: May 27, 2014

8.5K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Current stroke treatments, including tissue plasminogen activator (tPA) and mechanical thrombectomy, have limitations.
  • Post-stroke immune responses significantly contribute to brain damage and recovery.
  • There is a critical need for novel therapeutic strategies targeting these immune mechanisms.

Purpose of the Study:

  • To investigate the therapeutic potential of regulatory B (Breg) cells in experimental stroke models.
  • To evaluate the immunomodulatory effects and efficacy of Breg cell therapy in reducing stroke-induced damage.

Main Methods:

  • Experimental stroke was induced in mice.
  • Enriched Breg cell subpopulations were transferred into mice.
  • Immunosuppressive activities, including regulatory T cell potentiation, were assessed.
  • Stroke volumes and treatment outcomes were measured.

Main Results:

  • Breg cells demonstrated potent in vivo immunosuppressive activities.
  • Transfer of Breg cells led to the recruitment and potentiation of regulatory T cells.
  • Breg cell therapy significantly reduced stroke volumes and improved outcomes in mice.
  • Therapeutic effects were observed even when treatment was administered 24 hours post-stroke.

Conclusions:

  • Enriched Breg cell populations exhibit significant therapeutic potential for stroke.
  • Breg cell therapy offers a promising alternative with a broader treatment window compared to tPA.
  • Further clinical development is necessary to overcome challenges for human application.